NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Silver Creek Pharmaceuticals

Silver Creek Pharmaceuticals

Private
South San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.silvercreekpharma.com/

Last Round

Series B

Feb 5, 2018

Total Funding Raised

$16.99M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Silver Creek Pharmaceuticals is a clinical-stage biotechnology company that develops growth factor-based therapeutics designed to target and heal damaged tissues.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

targeted fusion proteinsacute ischemic strokegrowth factor therapyprotein engineeringregenerative medicinebiologicsneuroprotectionfirst-in-class therapytissue repairinsulin-like growth factor IIGF-1clinical stage pharmalate-window strokeapoptosis preventionscp776

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Silver Creek Pharmaceuticals Comparables

Compare Silver Creek Pharmaceuticals with similar companies based on industry and business-model similarity.

Silver Creek Pharmaceuticals comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ZZ Biotech
88%
NoNO Inc.
84%
Revalesio
79%

Silver Creek Pharmaceuticals Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BFeb 5, 2018
GrantMay 5, 2015
Series ADec 31, 2014

Key People

Founding team and executive leadership

Karim Dabbagh

Member Of The Board President CEO

Executive Team

Silver Creek Pharmaceuticals Investors

Notable investors and investment history

Silver Creek Pharmaceuticals investors
InvestorRounds
NIH RADxGrant
National Heart, Lung, and Blood InstituteGrant
Crocker VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 16, 2026

    Monthly visitors increased 108% MoM, reaching 2.4K.

  • Jun 2, 2025

    Monthly visitors increased 39% to 1,000.

Silver Creek Pharmaceuticals Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Silver Creek Pharmaceuticals Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Silver Creek Pharmaceuticals's valuation, stock price, and market status.

Firmographic Details

HeadquartersSouth San Francisco, California
Employee Range12
Year Founded2010
Last FundingFeb 5, 2018

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.